Americo Padilla
Child & Adolescent Psychiatry · Miami, FLNPI 1174564231
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Ironshore Pharmaceuticals Inc. accounts for 64.4% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $6,867 and has fallen 95.7% since, to $298 in 2025. Among child & adolescent psychiatry clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 181 payments — averaging $58.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$7K
- Sunovion Pharmaceuticals Inc.$1K
- Corium, LLC$717
- Tris Pharma Inc$554
- Takeda Pharmaceuticals U.S.A., Inc.$423
- Supernus Pharmaceuticals, Inc.$293
- plus $583 from 8 others
Across 150 payments — averaging $11,169 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim$519K
- Janssen Research & Development, LLC$391K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$210K
- Supernus Pharmaceuticals, Inc.$193K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$123K
- Biohaven Pharmaceutical Holding Company Ltd.$118K
- plus $122K from 6 others
What the payments were for
- Speaking & faculty fees$5,16048%
- Travel & lodging$9329%
- Food & beverage$4,57343%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 51 | $6,873 |
| Sunovion Pharmaceuticals Inc. | 23 | $1,223 |
| Corium, LLC | 35 | $717 |
| Tris Pharma Inc | 21 | $554 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $423 |
| Supernus Pharmaceuticals, Inc. | 14 | $293 |
| Shire North American Group Inc | 9 | $265 |
| Otsuka America Pharmaceutical, Inc. | 2 | $140 |
| Vertical Pharmaceuticals, LLC | 4 | $74 |
| Johnson & Johnson | 1 | $36 |
| Alkermes, Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Jornay PM 20mg capsules (Bottle of 100)$5,764
- LATUDA$820
- Dyanavel XR$191
- JORNAY PM$150
- REXULTI$120
How this compares
$10,665 in reported general payments places this provider in the 95th percentile of 206 child & adolescent psychiatry providers in Florida.
See all child & adolescent psychiatry providers in Florida →
Other child & adolescent psychiatry in Miami
- Sean HoranMiami$17K
- Jose AlvarezMiami$6K
- Nicole RedondoMiami$4K
- Gilbert SmithMiami$4K
- Jonathan ParkerMiami$4K
- Janeris LoredoMiami$3K
- Jerome SiegmeisterMiami$3K
- Mauricio RodriguezMiami$3K
- Yasin BezMiami$2K
- Craig KuninsGulfport$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.